DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 44 filers reported holding DEXCOM INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $9,430,872 | +1.6% | 3,336,000 | -1.0% | 0.00% | 0.0% |
| Q4 2022 | $9,284,000 | -32.9% | 3,371,000 | -51.6% | 0.00% | -40.0% |
| Q3 2022 | $13,827,000 | +7.9% | 6,971,000 | 0.0% | 0.01% | +25.0% |
| Q2 2022 | $12,813,000 | -52.4% | 6,971,000 | -13.9% | 0.00% | -55.6% |
| Q3 2021 | $26,931,000 | +27.9% | 8,101,000 | 0.0% | 0.01% | +28.6% |
| Q2 2021 | $21,053,000 | +17.9% | 8,101,000 | 0.0% | 0.01% | +16.7% |
| Q1 2021 | $17,852,000 | -1.9% | 8,101,000 | +1.2% | 0.01% | 0.0% |
| Q4 2020 | $18,191,000 | -10.0% | 8,001,000 | +0.0% | 0.01% | -25.0% |
| Q3 2020 | $20,210,000 | -9.5% | 8,000,000 | -11.1% | 0.01% | -20.0% |
| Q2 2020 | $22,326,000 | +16.1% | 9,000,000 | -18.2% | 0.01% | 0.0% |
| Q1 2020 | $19,230,000 | -3.8% | 11,000,000 | -18.5% | 0.01% | +25.0% |
| Q4 2019 | $19,996,000 | – | 13,500,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS INC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |